Angiogenesis Imaging Using (68)Ga-RGD PET/CT: Therapeutic Implications.

Eo, Jae Seon et al.·Seminars in nuclear medicine·2016·

Quick Facts

Study Type

Not classified

Evidence

Not graded

Sample

Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:: Angiogenesis Imaging Using (68)Ga-RGD PET/CT: Therapeutic Implications.
Published In:: Seminars in nuclear medicine, 46(5), 419-27 (2016)
Authors:: Eo, Jae Seon, Jeong, Jae Min
Database ID:: RPEP-02926

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

What do these levels mean? →

Cite This Study

RPEP-02926·https://rethinkpeptides.com/research/RPEP-02926

APA

Eo, Jae Seon; Jeong, Jae Min. (2016). Angiogenesis Imaging Using (68)Ga-RGD PET/CT: Therapeutic Implications.. Seminars in nuclear medicine, 46(5), 419-27. https://doi.org/10.1053/j.semnuclmed.2016.04.001

MLA

Eo, Jae Seon, et al. "Angiogenesis Imaging Using (68)Ga-RGD PET/CT: Therapeutic Implications.." Seminars in nuclear medicine, 2016. https://doi.org/10.1053/j.semnuclmed.2016.04.001

RethinkPeptides

RethinkPeptides Research Database. "Angiogenesis Imaging Using (68)Ga-RGD PET/CT: Therapeutic Im..." RPEP-02926. Retrieved from https://rethinkpeptides.com/research/eo-2016-angiogenesis-imaging-using-68gargd

Access the Original Study

View on PubMed View via DOI

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database